Technology Transformation in Clinical Trial Analysis

Abstract

We explore why clinical trials lag behind in innovation—even as the research side of drug development makes massive leaps. We’ll uncover why attracting top talent is critical to driving the industry forward, particularly in adopting open-source technologies. Dive into tools like R, test automation frameworks, and data abstractions, and learn how they’re reshaping tech transformation in clinical trials. Joining us are Novartis experts Orla Doyle and James Black to unpack the challenges and opportunities ahead.

Date
Mar 27, 2025 —
James Black
James Black
PhD (Cantab)

James Black. Kiwi | Epidemiologist | Data Scientist | Engineering enthusiast.